Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Jul;63(7):2229-31.
doi: 10.2337/db14-0566.

Beyond erythropoiesis: emerging metabolic roles of erythropoietin

Affiliations
Comment

Beyond erythropoiesis: emerging metabolic roles of erythropoietin

Minna Woo et al. Diabetes. 2014 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Erythroid and nonerythroid effects of EPO. Under hypoxic conditions, EPO promotes increased production of red blood cells (RBC). In the hypothalamus, EPO-Rs expressed in POMC-producing neurons regulate food intake and energy expenditure. In white adipose tissue, EPO decreases inflammation, normalizing insulin sensitivity and reducing glucose intolerance. In the pancreas, EPO exerts anti-apoptotic, anti-inflammatory, proliferative, and angiogenic effects on β-cells.

Comment on

References

    1. Ferrante AW., Jr The immune cells in adipose tissue. Diabetes Obes Metab 2013;15(Suppl. 3):34–38 - PMC - PubMed
    1. Koppaka S, Kehlenbrink S, Carey M, et al. Reduced adipose tissue macrophage content is associated with improved insulin sensitivity in thiazolidinedione-treated diabetic humans. Diabetes 2013;62:1843–1854 - PMC - PubMed
    1. Cravedi P, Manrique J, Hanlon KE, et al. Immunosuppressive effects of erythropoietin on human alloreactive t cells. J Am Soc Nephrol. 27 March 2014 [Epub ahead of print] - PMC - PubMed
    1. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 2003;228:1–14 - PubMed
    1. Thomas MC, Cooper ME, Tsalamandris C, MacIsaac R, Jerums G. Anemia with impaired erythropoietin response in diabetic patients. Arch Intern Med 2005;165:466–469 - PubMed